In vitro activity of norfloxacin and other antibacterial agents against gastro-intestinal pathogens isolated in Sweden

APMIS

Volumn 98, Issue 2, 1990, Pages 150-155

  Olsson Liljequist, B ^a   Mollby, R ^a  

^a National Bacteriological Laboratory   (Sweden)

Author keywords

Gastro intestinal pathogens; Norfloxacin

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; DOXYCYCLINE; ERYTHROMYCIN; NORFLOXACIN; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ANTIBACTERIAL ACTIVITY; ARTICLE; GASTROINTESTINAL INFECTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0025019370     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1990.tb01015.x     Document Type: Article

References (20)

1. Antimicrob. Agents Chemother. Barada Sulfamethoxazole-trimethoprim versus ampicillin in treatment of acute invasive diarrhea in adults 17 961 1980 10.1128/AAC.17.6.961
2. Scand. J. Infect. Dis. Bergan Effect of recent antibacterial agents against bacteria causing diarrhoea Suppl. 56 7 1988
3. Antimicrob. Agents Chemother. Carlson Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens 24 509 1983 10.1128/AAC.24.4.509
4. Lancet Mol Enteropathogenic agents in children with diarrhoea in rural Zaire i 516 1983 10.1016/S0140-6736(83)92202-X
5. Rev. Infect. Dis. Dupont Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole 4 533 1982 10.1093/clinids/4.2.533
6. Antimicrob. Agents Chemother. Goossens Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens 27 388 1985 10.1128/AAC.27.3.388
7. Lancet Gorbach Bacterial diarrhoea and its treatment ii 1378 1987 10.1016/S0140-6736(87)91267-0
8. Rev. of Infect. Dis. Gorbach Consensus development conference statement 8 Suppl. 2 S227 1986
9. Lancet Gracey Aeromonas-associated gastroenteritis ii 1304 1982 10.1016/S0140-6736(82)91510-0
10. Antimicrob. Agents Chemother. Johnson Lack of emergence of resistant fecal flora during successful prophylaxis of travelers' diarrhea with norfloxacin 30 671 1986 10.1128/AAC.30.5.671
11. J. Antimicrob. Chemother. Levy Multiple antibiotic resistance plasmids in Enterobacteriaceae isolated from diarrhoeal specimens of hospitalized children in Indonesia 16 7 1985 10.1093/jac/16.1.7
12. Acta path. microbiol. scand. Sect. B Ljungh Separation and characterization of enterotoxin and two haemolysins from Aeromonas hydrophila. 89 387 1981
13. Lancet Munshi Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1 ii 419 1987 10.1016/S0140-6736(87)90957-3
14. Rev. Infect. Dis. Murray Resistance of Shigella, Salmonella, and other selected enteric pathogens to antimicrobial agents 8 Suppl. 2 S172 1986 10.1093/clinids/8.Supplement_2.S172
15. MÖLlby Acute enteric infections in children. New prospects for treatment and prevention 159 1981
16. Drugs Exp. Clin. Res. O'Hare The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens XI 4 253 1985
17. Antimicrob. Agents Chemother. Shungu In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens 23 86 1983 10.1128/AAC.23.1.86
18. Antimicrob. Agents Chemother. Walder Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobial agents 16 37 1979 10.1128/AAC.16.1.37
19. Ann. Intern. Med. Wolfson Norfloxacin: A new targeted fluoroquinolone antimicrobial agent 108 238 1988 10.7326/0003-4819-108-2-238
20. J. Antimicrob. Chemother. Young Plasmid trimethoprim resistance in Vibrio cholerae: Migration of the type I dihydrofolate reductase gene out of the Enterobacteriaceae 17 697 1986 10.1093/jac/17.6.697